26

Nov2019

PDCI Market Access: PMPRB Reforms Briefing and Strategy Sessions (Toronto and Montreal)

REGISTRATION IS OPEN! Learn how the new PMPRB amendments and guidelines will affect your pharmaceutical pricing, negotiations and reimbursement Join PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, for industry-only sessions on the pricing guidelines, led by senior members ... Read More

31

Oct2019

INFOGRAPHIC: The Truth About the Federal Drug Pricing Reform

3Sixty Public Affairs and PDCI Market Access have collaborated to create an infographic that unmasks the reality behind the assumptions Health Canada has used to justify its ongoing drug pricing reforms (through the Patented Medicine Prices Review Board). When it comes to federal drug pricing reform in Canada, there is ... Read More

25

Oct2019

Keeley Farrell Joins PDCI Market Access!

PDCI is very pleased to welcome Keeley Farrell to the PDCI Team as Analyst, HTA and Clinical Evaluation. Keeley will help to support the development and preparation of the evidence-based clinical components of reimbursement and pricing submissions. She will also conduct research to support market access and ... Read More

12

Sep2019

PDCI Market Access: PMPRB Workshops (Toronto and Montreal)

REGISTRATION IS OPEN! Learn how the new PMPRB amendments and guidelines will affect your pharmaceutical pricing, negotiations and reimbursement Join PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, for industry-only sessions on the pricing guidelines, led by senior members of the PDCI team ... Read More

04

Jul2019

PDCI Announces Strategic Partnership with Goeree Consulting Ltd.

PDCI Market Access Inc. is pleased to announce a new Strategic Partnership with Goeree Consulting Ltd (owned and operated by Ron Goeree). Goeree Consulting and PDCI are bringing together an exceptional level of experience and expertise in health economics, while further expanding ... Read More

14

Jun2019

Forthcoming Revised PMPRB Guidelines

Mark down June 26th, 2019 in your calendars. It is now widely expected the patented medicines price regulations will be in Canada Gazette Part II (CGII), volume 151 No.13, which will be released on June 26th. Draft PMPRB Guidelines for consultation will likely be published immediately following CGII publication. Comments earlier this week from Federal Health Minister Petitpas-Taylor, appeared to confirm these expectations. When asked in an interview surrounding when changes to the ... Read More

02

May2019

Julia Shen Joins PDCI Market Access!

PDCI is very pleased to welcome Julia Shen to the PDCI Team as Associate, Corporate Marketing and Policy Research, effective April 23, 2019! Ms. Shen’s addition to the team reflects PDCI’s focus on continued growth with our current and new clients and our objective to expand services responding to the ... Read More

01

Apr2019

Helena Koa Joins PDCI Market Access!

We are very pleased to announce that Helena Koa has joined PDCI as Manager, Market Access, effective today, April 1, 2019! Helena brings a wealth of knowledge and multi-disciplinary insights to PDCI: new product development, pricing and reimbursement, clinical research, health economics, and budget impact analyses. Helena’s experience spans over ... Read More

22

Mar2019

PDCI’s New Associate Director, HTA & Health Economics

PDCI is very excited to announce the promotion of Jennifer Haig to the position of Associate Director, HTA and Health Economics. This promotion is effective immediately. Jen has been with PDCI for 18 months, and in that time has ... Read More

20

Mar2019

Kimberly Robinson Joins PDCI Market Access!

PDCI is excited to announce and welcome Kimberly Robinson as the newest member of the PDCI team. Kimberly will be joining as the Director of Pricing and Market Access effective April 1, 2019 and will be responsible for the leadership of PDCI’s Pricing/PMPRB team. She will be based in the ... Read More